Iconic Therapeutics
Manufacturing · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
701 Gateway Blvd Ste 100, South San Fran...Phone Number
(650) 437-1000Website
www.iconictherapeutics.comRevenue
$8.5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
2
1
1
1
1
1
About Iconic Therapeutics
Iconic Therapeutics, Inc. is a venture-backed biopharmaceutical company dedicated to translating an understanding of the role of Tissue Factor biology to new therapeutics for retinal disease, cancer, and potentially other serious diseases where Tissue Factor is over expressed. The company has developed a portfolio of proprietary molecules, which bind to and antagonize Tissue Factor expressed in disease, including in retina and in solid tumors.Explore more
Iconic Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Iconic Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Iconic Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Iconic Therapeutics has new funding data
Check out if Iconic Therapeutics is spiking on competitors!
Check if Iconic Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Iconic Therapeutics recently announced quarterly report
Product Launch: Get notified when Iconic Therapeutics launches new products
Congratulate Masked Content for being promoted to Masked Content at Iconic Therapeutics
Click to see if Iconic Therapeutics had a recent Job posting/layoffs
Recommended Actions
Find VP level buyers at Iconic Therapeutics
Find 2 more new buyers
Compare Similar Companies to Iconic Therapeutics
Compare insights from companies similar to Iconic Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Iconic Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Iconic Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Iconic Therapeutics.
Iconic Therapeutics financials insights
Gather financial insights about Iconic Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2004
Series A
$4.6M
2007
Other Financing Round
$1.3M
2009
Other Financing Round
$2.5M
2014
Series B
$20M
2016
Series C
$10M
Iconic Therapeutics Tech Stack
A closer look at the technologies used by Iconic Therapeutics
Most Recent Scoops
Lateral Move
Executive Move
Funding
, a biopharmaceutical company, recently secured $13.03 million in funding as part of a round targeted at $16.3 million.
Funding
Funding
Iconic Therapeutics recently secured $10 million in a Series C funding round.
Funding
Funding
Iconic Therapeutics recently secured $40 million in a Series C funding round.
Funding
Funding
Funding
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Iconic Therapeutics
Sign Up For FreeTo access detailed company insights
Iconic Therapeutics, Inc. is a venture-backed biopharmaceutical company dedicated to translating an understanding of the role of Tissue Factor biology to new therapeutics for retinal disease, cancer, and potentially other serious diseases where Tissue Factor is over expressed. The company has developed a portfolio of proprietary molecules, which bi... Read More
